Your browser doesn't support javascript.
loading
Subsequent chemotherapy with paclitaxel plus cetuximab-based chemotherapy following immune checkpoint inhibitor in recurrent or metastatic squamous cell carcinoma of the head and neck.
Tanaka, Hideki; Enokida, Tomohiro; Okano, Susumu; Fujisawa, Takao; Tanaka, Nobukazu; Takeshita, Naohiro; Onaga, Ryutaro; Hoshi, Yuta; Wada, Akihisa; Sato, Masanobu; Ueda, Yuri; Tahara, Makoto.
Afiliação
  • Tanaka H; Department of Head and Neck Medical Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
  • Enokida T; Department of Otorhinolaryngology-Head and Neck Surgery, Tokyo Medical University, Tokyo, Japan.
  • Okano S; Department of Head and Neck Medical Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
  • Fujisawa T; Department of Head and Neck Medical Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
  • Tanaka N; Department of Head and Neck Medical Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
  • Takeshita N; Department of Head and Neck Medical Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
  • Onaga R; Department of Head and Neck Medical Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
  • Hoshi Y; Department of Otorhinolaryngology, Jikei University School of Medicine, Tokyo, Japan.
  • Wada A; Department of Head and Neck Medical Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
  • Sato M; Department of Head and Neck Medical Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
  • Ueda Y; Department of Head and Neck Surgery, Tokyo Medical and Dental University, Tokyo, Japan.
  • Tahara M; Department of Head and Neck Medical Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
Front Oncol ; 13: 1221352, 2023.
Article em En | MEDLINE | ID: mdl-38074688

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Oncol Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Oncol Ano de publicação: 2023 Tipo de documento: Article